PCHM — PharmChem Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for PharmChem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2001 December 31st	2002 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	36.6	30.1	6.22	5.84	6.04
Cost of Revenue
Gross Profit	4.04	7.07	3.89	3.75	3.93
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	45.7	30.9	4.55	4.76	5.15
Operating Profit	-9.13	-0.783	1.67	1.08	0.894
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-9.56	-1.36	1.67	1.11	0.975
Provision for Income Taxes
Net Income After Taxes	-9.47	-1.29	1.85	0.87	0.723
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-8.48	3.34	1.85	0.87	0.723
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-8.48	3.34	1.85	0.87	0.723
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.48	-0.221	0.267	0.163	0.145
Dividends per Share
Special Dividends per Share